Summary
Beef insulin, pork proinsulin and four derivatives of beef insulin modified at the A1-B29 site on the molecular surface have been studied. Three derivatives had a synthetic crosslink between the A and B chains. Previous studies with these materials [2, 3 and 5] had demonstrated in vivo bioactivities which were much higher than those displayed in vitro. This paper reports experiments which explain this discrepancy. The analogues were administered at equimolar rates to anaesthetised greyhounds by a priming-dose constant infusion technique and the plasma concentrations achieved were estimated by radioimmunoassay. Proinsulin and the modified insulins were metabolised more slowly than insulin. Biopotency values, which related fall in plasma glucose concentration to the total administered dose of analogue, agreed broadly with published results of conventional in vivo bioassays. On the other hand, calculation of potency in relation to the serum concentration of analogue actually achieved, yielded results which agreed more closely with in vitro assay data. We conclude that for these analogues, reported discrepancies between in vitro and in vivo biopotencies can be largely explained by the different rates at which these materials are metabolised.
Article PDF
Similar content being viewed by others
References
Blundell, T. L., Dodson, G. G., Dodson, E., Hodgkin, D. C., Vijayan, M.: X-ray analysis and the structure of insulin. Recent Progr. Hormone Res.27, 1–40 (1971)
Freychet, P., Brandenburg, D., Wollmer, A.: Receptor-binding assay of chemically modified insulins. (Comparison of in vitro and in vivo bioassays). Diabetologia10, 1–5 (1974)
Gliemann, J., Gammeltoft, S.: The biological activity and the binding affinity of modified insulins determined on isolated fat cells. Diabetologia10, 105–113 (1974)
Gliemann, J., Sørensen, H. H.: Assay of insulin-like activity by the isolated fat cell method. IV. The biological activity of proinsulin. Diabetologia6, 499–504 (1970)
Brandenburg, D., Busse, W., Gattner, H., Zahn, H., Wollmer, A., Gliemann, J., Puls, W.: Structure-function studies with chemically modified insulins. Peptides 72: Proceedings of the Twelfth European Peptide Symposium, Reinhardsbrunn Castle, German Democratic Republic. September 1972, pp. 270–283. Amsterdam: North-Holland Publishing Company 1973
Lazarus, N. R., Penhos, J.C., Tanese, T., Michaels, L., Gutman, R., Recant, L.: Studies on the biological activity of porcine proinsulin. J. clin. Invest.49, 487–496 (1970)
Blundell, T., Dodson, G., Hodgkin, D., Mercola, D.: Insulin, the structure in the crystal and its reflection in chemistry and biology. Advanc Protein Chem.26, 279–402 (1972)
Brandenburg, D.: Preparation of NαA, NɛB29 adipoylinsulin, an intramolecularly crosslinked derivative of beef insulin. Hoppe-Seylers Z. physiol. Chem.353, 869–873 (1972)
Brandenburg, D., Gattner, H. G., Wollmer, A.: Darstellung und Eigenschaften von Acetylderivaten des Rinderinsulins. I. Hoppe-Seylers Z. physiol. Chem.353, 599–617 (1972)
Morgan, C. R., Lazarow, A.: Immunoassay of insulin. Two antibody system plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes12, 115–126 (1963)
Sönksen, P. H., Tompkins, C. V., Srivastava, M. C., Nabarro, J. D. N.: A comparative study on the metabolism of human insulin and porcine proinsulin in man. Clin. Sci.45, 633–654 (1973)
Greenwood, F. C., Hunter, W. M., Glover, J. S.: The preparation of131-I-labelled human growth hormone of high specific radioactivity. Biochem. J.89, 114–123 (1963)
Gliemann, J.: Assay of insulin-like activity by the isolated fat cell method. I. Factors influencing the response to crystalline insulin. Horm. Metab. Res.6, 12–16 (1964)
Moody, A. J., Stan, M. A., Stan, M., Gliemann, J.: A simple free fat cell bioassay for insulin. Horm. Metab. Res.6, 12–16 (1964)
Finney, D. J.: Statistical methods in biological assay. Second Edition, pp. 99–138. London: Griffin 1964
Ansorge, S., Bohley, P., Kirshke, H., Langner, J., Hanson, H.: Metabolism of insulin and glucagon. Breakdown of radioinodinated insulin and glucagon in rat liver cell fractions. Europ. J. Biochem.19, 283–288 (1971)
Terris, S., Steiner, D. F.: Binding and degradation of125I-insulin by rat hepatocytes. J. biol. Chem.250, 8389–8398 (1975)
Terris, S., Steiner, D. F.: Retention and degradation of125I-insulin by perfused livers from diabetic rats. J. clin. Invest.57, 885–896 (1976)
Tompkins, C. V., Sönksen, P. H., Jones, R. H.: Structural modifications to the insulin molecule and their effects on glucose metabolism. J. Endocr.65, 59 (1975)
The Shanghai Insulin Research Group: Studies on the structure-function relationships of insulin. I. The relationship of the C-terminal peptide sequence of B-chain to the activity of insulin. Scientia Sinica16, 61–70 (1973)
Wood, S. P., Blundell, T. C., Wollmer, A., Lazarus, R., Neville, R. W. J.: The relation of conformation and association of insulin to receptor binding: X-ray and circular dichroism studies on bovine and hystricomorph insulins. Europ. J. Biochem.55, 531–542 (1975)
Pullen, R. A., Lindsay, D. G., Wood, S. P., Tickle, I. J., Blundell, T. L., Wollmer, A., Krail, G., Brandenburg, D., Zahn, H., Gliemann, J., Gammeltoft, S.: Receptor-binding region of insulin. Nature259, 369–373 (1976)
Snell, C. R., Smyth, D. G.: Proinsulin — a proposed three dimensional structure. J. biol. Chem.250, 6291–6295 (1975)
Freychet, P.: The interactions of proinsulin with insulin receptors on the plasma membrane of the liver. J. clin. Invest.54, 1020–1031 (1974)
Author information
Authors and Affiliations
Additional information
Dedicated to Professor H. Zahn on the occasion of his 60th birthday
Rights and permissions
About this article
Cite this article
Jones, R.H., Dron, D.I., Ellis, M.J. et al. Biological properties of chemically modified insulins. I. Biological activity of proinsulin and insulin modified at A1-glycine and B29-lysine. Diabetologia 12, 601–608 (1976). https://doi.org/10.1007/BF01220637
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01220637